United Kingdom: Competition and Markets Authority announced review of merger remedies approach

On 21 November 2024, the Competition and Markets Authority (CMA) announced a review of its approach to merger remedies. Remedies are measures imposed to address competition concerns arising from mergers, which may include structural changes, such as selling part of a business, or behavioural commitments, such as ensuring fair access to services. The review will examine when behavioural remedies may be appropriate, how efficiency gains can be considered, and the role of customer benefits in decision-making. The CMA will seek input from businesses, investors, and other stakeholders as part of this process.